Go to the list of all blogs
published in Blogs
May 01, 2026
Northrop Grumman (NOC) Drops -17% in the Past 30 Days: Breaking Down the Key Drivers

Northrop Grumman (NOC) Drops -17% in the Past 30 Days: Breaking Down the Key Drivers

Key Takeaways

  • NOC declined approximately -17% over the past 30 days, primarily due to a sharp selloff following Q1 2026 earnings despite beating estimates, driven by concerns over cash burn and a Space Systems charge.
  • Over the past quarter, the stock fell around -20%, reflecting a retreat from March highs amid broader defense sector pressures and uncertainty on program profitability.
  • Strong backlog of $95.6 billion and anticipated revenue growth provide a supportive backdrop, but higher capital expenditures (capex) and fixed-price contract risks weighed on sentiment.
  • Sector performance in aerospace and defense showed mixed results, with NOC underperforming peers amid post-earnings reactions.
  • Macro trends like rising U.S. defense budgets offer tailwinds, though near-term cash flow challenges dominated.

Understanding Northrop Grumman (NOC) and Its Portfolio

Northrop Grumman Corporation (NOC) stands out as a leading aerospace and defense technology company, offering investors targeted exposure to critical U.S. national security programs. The company operates across four key segments: Aeronautics Systems (including advanced aircraft like the B-21 Raider), Defense Systems (missile defense and weapons), Mission Systems (cyber, radar, and intelligence solutions), and Space Systems (satellites and launch systems). This diversified structure, backed by a substantial $95.6 billion backlog, provides strong long-term revenue visibility. From what I see, NOC's performance is closely linked to government contracts and defense spending trends, which helps explain the recent volatility as investors balanced solid earnings against execution risks in programs like the Sentinel missile.

NOC Price Action: 30-Day and Quarterly Review

In the last 30 days from April 1 to April 30, 2026, NOC's price fell from $697 to $579.48, marking a -17% decline. The drop was volatile and downward-trending, with a particularly sharp post-earnings plunge between April 21-23.

Over the past quarter, from late February to April 30, 2026, the stock declined from around $724 to $579.48, down -20%. It stayed range-bound initially before a steeper correction, mirroring broader market shifts away from defense stocks.

I also looked at this performance through Tickeron’s AI Screener to compare NOC against sector peers.

Key Factors Behind NOC's 30-Day Decline

The main driver of NOC's -17% drop over the last 30 days was the market's response to its Q1 2026 earnings, released around April 21. Even with revenue of $9.88 billion surpassing estimates by 1.2% and reaffirmed full-year guidance, shares fell sharply due to higher-than-expected cash burn, increased capex, and a charge in the Space Systems segment. Investors zeroed in on free cash flow misses and risks from fixed-price development contracts, such as the Ground Based Strategic Deterrent (Sentinel). This was compounded by a wider defense sector selloff, where peers like RTX and LMT also came under pressure. In my view, NOC's focus on capital-intensive, mission-critical projects made it especially sensitive to these issues, overshadowing strengths like backlog expansion.

What Shaped NOC's Quarterly Performance

NOC's -20% drop over the quarter followed a peak near $774 in early March, with ongoing downward pressure. Contributing factors included fading momentum in defense stocks after an early surge linked to geopolitical events like the Iran conflict, which didn't hold. Company-specific challenges, such as rising costs in programs like B-21 acceleration and Sentinel, fueled doubts about profitability. While macroeconomic supports like stable interest rates and strong U.S. defense budget outlooks helped, they couldn't counter earnings concerns. Shifts in institutional positioning due to higher capex guidance added to the trend. Overall, execution risks in Space and Aeronautics segments had the most significant impact.

Leveraging Tickeron’s AI Screener in My Analysis

In my research process, I frequently turn to Tickeron’s AI Screener, an AI-powered tool for discovering stocks and ETFs. It lets me filter thousands of assets using criteria like technical patterns, fundamentals, trends, volatility, and AI signals—covering industry, market cap, indicators, price patterns, and performance metrics. This helps pinpoint trade ideas, trending names, breakouts, and opportunities far more efficiently than manual methods. I've found it particularly useful for sectors like aerospace and defense, where it highlights potential plays amid volatility. If you're scanning for similar setups, it's worth exploring.

What to Watch Next for NOC Investors

Looking ahead, keep an eye on U.S. defense budget updates, especially FY2027 funding for programs like B-21 and Sentinel. Monitor contract awards, backlog execution, and cash flow progress in coming quarters. The sector's direction will depend on geopolitical tensions and military spending. Segment performance, particularly Space Systems after the recent charge, will be key. Risks persist from fixed-price contract overruns and capex strains, but opportunities may arise from production ramps or sector recovery. This is important because it could signal a shift in sentiment.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations

Related Ticker: NOC

NOC's RSI Oscillator leaves overbought zone

The 10-day RSI Oscillator for NOC moved out of overbought territory on August 17, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 instances where the indicator moved out of the overbought zone. In of the 36 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NOC as a result. In of 72 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for NOC turned negative on August 21, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NOC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

NOC moved above its 50-day moving average on July 31, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for NOC crossed bullishly above the 50-day moving average on August 03, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NOC advanced for three days, in of 327 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 242 cases where NOC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.376) is normal, around the industry mean (7.037). P/E Ratio (17.515) is within average values for comparable stocks, (60.208). Projected Growth (PEG Ratio) (3.806) is also within normal values, averaging (8.077). Dividend Yield (0.017) settles around the average of (0.017) among similar stocks. P/S Ratio (1.834) is also within normal values, averaging (20.174).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. NOC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 40.4B. The market cap for tickers in the group ranges from 4.49 to 1.81T. SPCX holds the highest valuation in this group at 1.81T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was -8%. For the same Industry, the average monthly price growth was 8%, and the average quarterly price growth was -3%. NPK experienced the highest price growth at 7%, while DFSC experienced the biggest fall at -48%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was -31%. For the same stocks of the Industry, the average monthly volume growth was -5% and the average quarterly volume growth was -7%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 68
Price Growth Rating: 55
SMR Rating: 78
Profit Risk Rating: 73
Seasonality Score: -30 (-100 ... +100)
View a ticker or compare two or three
NOC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of innovative systems, products and solutions in aerospace, electronics and information systems

Industry AerospaceDefense

Profile
Details
Industry
Aerospace And Defense
Address
2980 Fairview Park Drive
Phone
+1 703 280-2900
Employees
101000
Web
https://www.northropgrumman.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.